作者: Marie Brevet , Maria Arcila , Marc Ladanyi
DOI: 10.2353/JMOLDX.2010.090140
关键词:
摘要: … on EGFR TKIs than with conventional cytotoxic chemotherapy. EGFR-mutant lung adenocarcinomas also form a distinct clinically favorable biological subset, regardless of EGFR TKI …